CNS Neuroscience & Therapeutics, 2020 · DOI: 10.1111/cns.13368 · Published: July 1, 2020
Spinal cord injury (SCI) can cause lasting damage, and after the initial injury, the body's own processes can make it worse. This study looks at a treatment called immunization with neural-derived peptides (INDP). INDP has shown promise in helping with recovery in the later, chronic stages of SCI. This study investigates if INDP can encourage the growth of new nerve cells (neurogenesis) in rats with chronic SCI. The study found that INDP treatment led to improved motor and sensory function, increased neurogenesis in the injured spinal cord, and a boost in anti-inflammatory and regenerative proteins.
INDP could be a promising therapeutic approach for improving motor and sensory recovery in individuals with chronic SCI.
The neurogenic effects of INDP may extend to other trauma-related disorders, such as traumatic brain injury, warranting further investigation.
This study highlights the importance of neurogenesis in the chronic stages of SCI and the potential for therapeutic interventions to enhance this process.